Omega Pharma Said to Explore Sale of More Than $4 Billion

Omega Pharma NV, the Belgian over-the-counter health-care company, is exploring a sale of the business almost three years after it was taken private by its founder, people familiar with the matter said.

A sale of Nazareth, Belgium-based Omega Pharma could fetch more than $4 billion, one of the people said, and would follow deals by companies including Merck & Co., which raised $14.2 billion from selling its consumer-care unit in May. Omega Pharma is working with Morgan Stanley on the sale, which could start as early as this month, according to the people, who asked not to be identified because the process is private.